Israel - engelska - Ministry of Health

cts ltd - ferric carboxymaltose - solution for injection / infusion - ferric carboxymaltose 1800 mg/vial - ferinject is indicated for treatment of iron deficiency when oral iron preparations are ineffective or cannot be used. the diagnosis must be based on laboratory tests.

Israel - engelska - Ministry of Health

cts ltd - ferric carboxymaltose - solution for injection / infusion - ferric carboxymaltose 1800 mg/vial - ferinject is indicated for treatment of iron deficiency when oral iron preparations are ineffective or cannot be used. the diagnosis must be based on laboratory tests.

Malaysia - engelska - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fresenius kabi malaysia sdn. bhd - sucroferric oxyhydroxide -

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - ferric carboxymaltose 180mg equivalent to iron 50mg - solution for injection - 50 mg/ml - active: ferric carboxymaltose 180mg equivalent to iron 50mg excipient: hydrochloric acid sodium hydroxide water for injection - indicated for the treatment of iron deficiency when oral iron preparations are ineffective, oral preparations cannot be used or there is a clinical need to deliver iron rapidly.

Singapore - engelska - HSA (Health Sciences Authority)

vifor pharma asia pacific pte. ltd. - iron eqv iron sucrose - injection - 100 mg/5 ml - iron eqv iron sucrose 100 mg/5 ml

Singapore - engelska - HSA (Health Sciences Authority)

vifor pharma asia pacific pte. ltd. - etamsylate - capsule - 500mg

Australien - engelska - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - iron polymaltose, quantity: 185 mg/ml (equivalent: iron, qty 50 mg/ml) - oral liquid - excipient ingredients: sodium propyl hydroxybenzoate; sodium methyl hydroxybenzoate; purified water; sucrose; sodium hydroxide; flavour - treatment of iron deficiency in adults and adolescents where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate.,prevention of iron deficiency in adults and adolescents at high risk where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - iron polymaltose, quantity: 37 mg/ml (equivalent: iron, qty 10 mg/ml) - oral liquid - excipient ingredients: propyl hydroxybenzoate; purified water; sorbitol solution (70 per cent) (non-crystallising); ethanol; sucrose; sodium hydroxide; methyl hydroxybenzoate; flavour - treatment of iron deficiency in adults and adolescents where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate. prevention of iron deficiency in adults and adolescents at high risk where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - iron polymaltose, quantity: 370 mg (equivalent: iron, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; macrogol 6000; crospovidone; magnesium stearate; titanium dioxide; hypromellose; hyprolose; iron oxide yellow; iron oxide red - treatment of iron deficiency in adults and adolescents where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate. prevention of iron deficiency in adults and adolescents at high risk where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate.

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

vifor pharma uk ltd - etamsylate - oral tablet - 500mg